Also published in GlobeNewswire:
NACD Directorship 100 Forum Focused on Reinvigorating America
x hide permanently

Vaxart Appoints Karen J. Wilson to its Board of Directors

GlobeNewswire

Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced the appointment of Karen J. Wilson to its Board of Directors and as chair of its Audit Committee...

Mentions: Nasdaq Audit Committee Vaxart